Global Digital Respiratory Devices Market (2021 to 2030) - Featuring 3M, Adherium and Amiko Digital Health Among Others

Research and Markets
·9 min read

Dublin, April 16, 2021 (GLOBE NEWSWIRE) -- The "Global Digital Respiratory Devices Market 2021-2030: Focus on Sensors, Smart Inhalers & Nebulizers, Application, 9 Countries' Data, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030. The study highlights that the market is set to witness a CAGR of 27.31% between 2021 and 2030.

This comprehensive study of the global digital respiratory devices market covers the following:

  • Market numbers on product types

  • More than 35 key products present in the market

  • Market share analysis for the global digital respiratory devices Market and its indications

  • Detailed global and regional market share analysis

Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, end-user analysis, and COVID-19 impact on the market.

The study indicates that increasing prevalence of respiratory diseases, increasing adoption of digital technology among individuals, and treatment satisfaction with inhaled therapy among individuals are fueling the growth of the market.

The study highlights the various emerging opportunities, such as expansion into the emerging markets and predicting future exacerbations, which can be leveraged by players operating in the market.

Scope of the Report

The purpose of the study is to enable the reader to gain a holistic view of the Global Digital Respiratory Devices Market.

The report constitutes an in-depth analysis of the global digital respiratory devices market, including a thorough analysis of the different end-users. The study also provides exhaustive information on competitive landscape, brand share landscape, market share of the leading players, as well as other vital information with respect to the global digital respiratory devices market. The report considers sensors and apps, and smart inhalers and nebulizers.

Key Companies

Some of the key players contributing to the Global Digital Respiratory Devices Market include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.

Key Questions Answered in this Report

  • How pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?

  • What has been the impact of the COVID-19 pandemic on global digital respiratory devices market?

  • What are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?

  • How will the pharma industry evolve in terms of drug-based devices in the future?

  • What are the potential business models in global digital respiratory devices market?

  • What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?

  • What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?

  • What was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?

  • How is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?

  • What are the influencing factors that may affect the market share of the key players?

  • What is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?

How can market intelligence on digital respiratory device add value to an organization's decision-making process?

  • Aid in product development

  • Aid in understanding the key developments of the market

  • Help in targeting a segment for launching a new product

  • Support in diversifying the product portfolio for digital respiratory solutions

  • Aid in understanding market potential of different digital respiratory devices

  • Aid in understanding digital respiratory devices penetration in different indications

  • Support in analyzing the market opportunities

  • Insights on the key companies in the market

Key Topics Covered:

1 Market Overview
1.1 Introduction
1.2 Digital Respiratory Devices Market Ecosystem
1.3 Assumptions and Limitations

2 Market Dynamics
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Increasing Prevalence of Respiratory Diseases
2.2.2 Increasing Adoption of Digital Technology Among Individuals
2.2.3 Treatment Satisfaction with Inhaled Therapy Among Individuals
2.3 Market Restraints
2.3.1 Issues Related to The Accuracy and Reliability of the Device
2.3.2 Availability and High Cost Associated with Digital Respiratory Devices
2.4 Market Opportunities
2.4.1 Expansion into the Emerging Markets
2.4.2 Predicting Future Exacerbations

3 Analysis of COVID-19 Impact on Global Digital Respiratory Devices Market
3.1 Impact on Market Size
3.1.1 Scenario Comparative Analysis (Pre-COVID-19, During-COVID-19, Post-COVID-19)
3.1.2 Regional Impact
3.1.2.1 North America
3.1.2.2 Europe
3.1.2.3 Asia-Pacific
3.2 Impact on Digital Respiratory Devices Adoption
3.2.1 Short-Term Impact (2-4 Years)
3.2.2 Mid-Term Impact (5-8 Years)
3.2.3 Long-Term Impact (9-12 Years)
3.3 Entry Barrier and Opportunities for New Entrants

4 Competitive Landscape
4.1 Key Developments and Strategies
4.1.1 Agreements and Collaborations
4.1.2 Regulatory and Legal Activities
4.1.3 Investments, Funding, and Business Expansion
4.1.4 Mergers and Acquisitions
4.1.5 Awards and Recognitions
4.1.6 Product Launches
4.2 Market Share Analysis
4.3 Industry Attractiveness
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyer
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 Industry Insights
5.1 Opportunity Map Analysis of Smart Inhalers and Nebulizers
5.2 Smart Inhaler Value Propositions for Stakeholders
5.3 Smart Inhalers and Nebulizers - An Important Element of System for Predicting Disease Worsening in Individuals
5.4 Business Models for Digital Respiratory Devices Market

6 Global Digital Respiratory Devices Market (by Product Type)
6.1 Sensors and Apps
6.2 Smart Inhalers and Nebulizers

7 Global Digital Respiratory Devices Market (by Indication)
7.1 Asthma
7.2 Chronic Obstructive Pulmonary Disease (COPD)

8 Global Digital Respiratory Devices Market (by Region)
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 U.K.
8.2.3 France
8.2.4 Rest-of-Europe
8.3 Asia-Pacific (APAC)
8.3.1 Japan
8.3.2 China
8.3.3 Australia
8.3.4 India
8.3.5 Rest-of-Asia-Pacific (RoAPAC)
8.4 Rest-of-the-World (RoW)

9 Company Profiles
9.1 3M Health Care Limited
9.1.1 Company Overview
9.1.2 Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market
9.1.3 Financials
9.1.3.1 Key Insights on the Financial Health of the Company
9.1.4 SWOT Analysis
9.2 Adherium Limited
9.2.1 Company Overview
9.2.2 Role of Adherium Limited in the Global Digital Respiratory Devices Market.
9.2.3 Financials
9.2.3.1 Key Insights on the Financial Health of the Company
9.2.4 SWOT Analysis
9.3 Amiko Digital Health Limited
9.3.1 Company Overview
9.3.2 Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market
9.3.3 SWOT Analysis
9.4 AstraZeneca plc
9.4.1 Company Overview
9.4.2 Role of AstraZeneca plc in the Global Digital Respiratory Devices Market
9.4.3 Financials
9.4.3.1 Key Insights on the Financial Health of the Company
9.4.4 SWOT Analysis
9.5 Boehringer Ingelheim International GmbH
9.5.1 Company overview
9.5.2 Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market
9.5.3 Financials
9.5.3.1 Key Insights on the Financial Health of the Company
9.5.4 SWOT Analysis
9.6 Capsule Technologies, Inc.
9.6.1 Company Overview
9.6.2 Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market.
9.6.3 SWOT Analysis
9.7 Cognita Labs
9.7.1 Company Overview
9.7.2 Role of Cognita Labs in the Global Digital Respiratory Devices Market
9.7.3 SWOT Analysis
9.8 Cohero Health
9.8.1 Company Overview
9.8.2 Role of Cohero Health in the Global Digital Respiratory Devices Market
9.8.3 SWOT Analysis
9.9 Findair Sp. z. o. o
9.9.1 Company Overview
9.9.2 Role of Findair Sp. z. o. o in the Global Digital Respiratory Devices Market
9.9.3 SWOT Analysis
9.1 GlaxoSmithKline plc
9.10.1 Company overview
9.10.2 Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market
9.10.3 Financials
9.10.3.1 Key Insights on the Financial Health of the Company
9.10.4 SWOT Analysis
9.11 Novartis AG
9.11.1 Company overview
9.11.2 Role of Novartis AG in the Global Digital Respiratory Devices Market
9.11.3 Financials
9.11.3.1 Key Insights on the Financial Health of the Company
9.11.4 SWOT Analysis
9.12 Pneuma Respiratory, Inc.
9.12.1 Company Overview
9.12.2 Role of Pneuma Respiratory, Inc. in the Global Digital Respiratory Devices Market
9.12.3 SWOT Analysis
9.13 Propeller Health
9.13.1 Company Overview
9.13.2 Role of Propeller Health in the Global Digital Respiratory Devices Market
9.13.3 SWOT Analysis
9.14 Sensirion AG
9.14.1 Company overview
9.14.2 Role of Sensirion AG in the Global Digital Respiratory Devices Market
9.14.3 Financials
9.14.3.1 Key Insights on the Financial Health of the Company
9.14.4 SWOT Analysis
9.15 Teva Pharmaceuticals Industries Ltd.
9.15.1 Company Overview
9.15.2 Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market
9.15.3 Financials
9.15.3.1 Key Insights on the Financial Health of the Company
9.15.4 SWOT Analysis

10 Research Scope and Methodology

For more information about this report visit https://www.researchandmarkets.com/r/6foqj6

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900